Here at Zacks, we used to have a service called “Follow the Money.” Similar to Insider Trader and how it follows insider buying, FTM used to follow institutional investor announcements. In today’s day ...

This month, tempus’s generative AI (genAI) assistant, Tempus One, launched a range of new capabilities for running queries on millions of unstructured documents for research and clinical care.

Tempus recently gained in-network provider status with Blue Cross Blue Shield across multiple states, allowing for the firm's tests to be covered by insurance. One of Tempus’ business objectives ...

On January 14, the company unveiled a suite of new, transformative capabilities available in Tempus One, the company’s generative AI assistant. Tempus One, the company’s generative AI-enabled ...

In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ ... annually over a decade. “Britain will be one of the great AI superpowers. We’re going to make the breakthroughs, we’re ...

Tempus AI is a leading player in healthcare AI, aiming to deliver personalized treatment suggestions through its proprietary data model. Preliminary Q4 results and 2025 guidance show mixed ...

Thursday's 55-25 final was strikingly similar, though it looked like Cowan was going to keep this one closer after a slow start by the Broncos. "We just came out a little bit flat ... but once we ...

transformative capabilities available in Tempus One, the company's generative AI assistant. Tempus One, which initially launched in 2023, provides both physicians and researchers AI-enabled services ...